Oral contraceptive market expands
By Whang, byung-woo | translator Hong, Ji Yeon
24.12.18 05:31:42
가나다라
0
Despite the introduction of generics in 2021, Yaz maintains its status as the market leader
Indications for oral contraception and menstruation-related diseases positively impact sales
The market for prescription drugs+OTCs has been growing…increasing market share remains as a task
As the oral contraceptive market expands, Yaz seems to maintain its market share despite the introduction of generics.
According to a report by global market research firm Research and Markets, the global oral contraceptive market is expected to grow from approximately KRW 33.8 trillion (USD 23.6 billion) in 2023 to around KRW 67.3 trillion (USD 47.1 billion) by 2028.
▲Product photo of Yaz.
The South Korean market also shows a consistent growth rate, similar to the global trend, with a market size of approximately KRW 42 billion in 2023, encompassing both prescription drugs and over-the-counter drugs.Contraceptives, which contain hormones such as estrogen and progesterone, are classified into fo
Whang, byung-woo(tuai@dailypharm.com)
If you want to see the full article, please JOIN US (click)